Fundraising Fox
/Companies
Sign in

Brenig

Dover, US · Founded 2021 · 4 employees on LinkedIn · 4 known investors

Find your way into Brenig

Sign up to see every warm intro you have to Brenig

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Brenig team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Brenig Therapeutics is a biotechnology company developing small-molecule therapies for Parkinson's disease and other neurodegenerative disorders, using AI-driven drug discovery. Its pipeline includes BT-267, a brain-penetrant LRRK2 inhibitor, and BT-409, an NLRP3 inflammasome inhibitor.

AI & Machine LearningBiotechHealthtech

Founders & leadership

MMMegan McGill
Megan McGillChief Executive OfficerMegan McGill is a physician and radiologist who has held strategy and business development roles at gene therapy and genetic medicines companies, including Regenxbio and Ultragenyx. She is CEO of Brenig Therapeutics.
IDIain Dukes
Iain DukesChief Business Officer / Chairman of the BoardVenture Partner at OrbiMed
NSNikolay Savchuk
Nikolay SavchukChief Operating OfficerManaging Member at Torrey Pines Investment
TDTien Dam
Tien DamChief Medical OfficerTien Dam is an academic clinician and drug development researcher with experience in neuroscience across pharmaceutical and biotech companies, where he has led programs in neurological and neuropsychiatric indications including Parkinson's disease, movement disorders, and psychiatric conditions.

Investors · 4

OrbiMed✓ confirmed by BrenigNew York · $1M – $75M

How we know: OrbiMed's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us

BGV✓ confirmed by BrenigSilicon Valley

How we know: the company's own site · Not right? Tell us

Torrey Pines Investment✓ confirmed by BrenigSan Diego

How we know: the company's own site · Not right? Tell us

Founder mafia

2 people who came through Brenig went on to found or lead other companies.

Iain DukesChief Business Officer / Chairman of the BoardFounded Lomondther +5Keno GutierrezBoard MemberFounded Brandaris Therapeutics

Frequently asked questions

What does Brenig do?
Brenig Therapeutics is a biotechnology company developing small-molecule therapies for Parkinson's disease and other neurodegenerative disorders, using AI-driven drug discovery. Its pipeline includes BT-267, a brain-penetrant LRRK2 inhibitor, and BT-409, an NLRP3 inflammasome inhibitor.
Who are Brenig's investors?
Brenig's investors include New Enterprise Associates (NEA), OrbiMed, BGV, Torrey Pines Investment.
Where is Brenig headquartered?
Brenig is headquartered in Dover, US.